EOADYUVANTE PHASE 2 STUDY USING GEMCITABIN ASSOCIATED WITH DOXORRUBICINE FOR THE TREATMENT OF BREAST CANCER CLINICAL STAGE III-B
Not Applicable
Completed
- Conditions
- -C50 Malignant neoplasm of breastMalignant neoplasm of breastC50
- Registration Number
- PER-003-00
- Lead Sponsor
- ELI LILLY INTERAMERICA INC.,
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
NA
Exclusion Criteria
NA
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method